The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes and adverse events of low-dose nivolumab in platinum refractory head and neck cancers.
 
Hemanth Kumar
No Relationships to Disclose
 
Jatin Choudhary
No Relationships to Disclose
 
Madala Ravikrishna
No Relationships to Disclose
 
Nandini Sharrel Menon
No Relationships to Disclose
 
Vijay Maruti Patil
Research Funding - AstraZeneca (Inst); Eisai Germany (Inst); Intas (Inst); Johnson & Johnson/Janssen (Inst); NATCO Pharma (Inst); Novartis (Inst)
 
Vanita Noronha
Research Funding - Amgen (Inst); AstraZeneca (Inst); Dr. Reddy's Laboratories (Inst); Intas (Inst); Sanofi/Aventis (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology
 
Kumar Prabhash
Research Funding - Alkem Laboratories (Inst); BDR Pharmaceutics (Inst); Biocon (Inst); Dr. Reddy's Laboratories (Inst); Fresenius Kabi (Inst); NATCO Pharma (Inst); Roche (Inst)
 
Amit Joshi
No Relationships to Disclose